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Abstract 
There is growing evidence for the efficacy and effectiveness of psychotherapy in patients with 
personality disorder (PD), but very little is known about the factors underlying these effects. 
Two-polarities models of personality development provide an empirically supported approach to 
studying therapeutic change. Briefly, these models argue that personality pathology is 
characterized by an imbalance between development of the capacity for self-definition and for 
relatedness, with an exaggerated emphasis on issues regarding self-definition and relatedness 
being expressed in high levels of self-critical perfectionism (SCP) and dependency, respectively. 
This study used data from a study of 111 patients with PD who received long-term 
hospitalization-based psychodynamic treatment, to investigate whether (a) treatment was related 
to changes in SCP, dependency, and symptomatic distress; (b) these changes could be explained 
by pretreatment levels of SCP, dependency, and/or symptomatic distress; and (c) changes in 
these personality dimensions over time were associated with symptomatic improvement. SCP, 
dependency, and symptomatic distress were assessed at admission (baseline), at 12 and 24 weeks 
into treatment, and at discharge. Parallel process multilevel growth modeling showed that (a) 
treatment was associated with a significant decrease in levels of SCP, dependency, and 
symptomatic distress, whereas (b) pretreatment levels of each of these three factors did not 
predict the decreases observed, and (c) changes in SCP, but not dependency, were associated 
with the rate of decrease in symptomatic distress over time. Implications of these findings for our 
understanding of therapeutic change in the treatment of PD are discussed. 
Keywords: Personality disorder, self-critical perfectionism, dependency, psychodynamic 
psychotherapy, parallel process growth model  
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Personality disorders (PDs) are characterized by chronic, pervasive, and inflexible 
aberrant inner experiences and behaviors (American Psychiatric Association, 2013). Besides 
pharmacological treatment, guidelines currently recommend psychotherapy as a primary 
intervention in PDs (e.g., Clarkin, Levy, Lenzenweger, & Kernberg, 2007; Fonagy, 2015). Yet, 
very little is known about the factors underlying these effects.  
Two-polarities models of personality development (e.g., Beck, Epstein, Harrison, & 
Emery, 1983; Luyten & Blatt, 2013) have provided one of the most productive theory-driven 
approaches conceptualizing and assessing therapeutic change. According to these models, 
normal personality development involves a lifelong dialectical interaction between the 
development of (a) relatedness, which refers to the development of increasingly mature, 
complex, and satisfying interpersonal relationships, and (b) self-definition, which refers to the 
development of an increasingly differentiated, integrated, and essentially positive sense of self. 
Hence, personality pathology can be defined in terms of a severe imbalance or an exaggerated 
preoccupation with one developmental line, at the neglect and/or the defensive avoidance of the 
other. Blatt (2008) introduced the notions of self-critical perfectionism (SCP) and dependency to 
refer to imbalances between relatedness and self-definition. Individuals with high levels of SCP 
are typically strongly concerned with issues of self-definition, achievement, self-esteem, and 
self-control, while neglecting interpersonal relationships. Individuals with high levels of 
dependency, in contrast, have strong needs to be loved and cared for, fear of being left alone, and 
define themselves primarily in terms of the quality of their interpersonal experiences. These 
formulations are consistent with recent formulations on personality pathology (e.g., Bender, 
Morey, & Skodol, 2011), with a recent proposal for the conceptualization and classification of 
PDs in DSM-5 (American Psychiatric Association, 2013), and with studies that have suggested 
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that personality pathology is indeed associated with impairments in relatedness and self-
definition (e.g., Lowyck, Luyten, Verhaest, Vandeneede, & Vermote, 2013; Ouimette, Klein, 
Anderson, Riso, & Lizardi, 1993). In addition, this view also argues that all effective treatments, 
regardless of their theoretical orientation, lead to a reactivation of the dialectic interaction 
between these two capacities, such that higher levels of relatedness lead to higher levels of self-
definition and vice versa. 
Existing research in this area has focused either on symptom disorders, such as 
depression and social phobia (e.g., Cox, Walker, Enns & Karpinski, 2002; Hawley, Ho, Zuroff, 
& Blatt, 2006) or on longitudinal associations between changes in respectively borderline PD 
symptoms (e.g., Wright, Hopwood, and Zanarini, 2015), and symptoms related to the avoidant 
personality disorder (e.g., Wright, Pincus, & Lenzenweger, 2013) and changes in normal 
personality traits. No studies to date have directly investigated the assumption that changes in 
self-definition and relatedness are associated with symptomatic improvement in PD patients 
during their treatment.  
 
The Present Study 
Using a parallel process multilevel growth modeling approach, this study investigated 
whether (a) there is a significant decrease in SCP and dependency, and symptomatic distress, 
from the start to the end of treatment, (b) pretreatment levels of SCP and dependency are 
negatively associated with symptomatic change, and (c) changes in SCP and dependency are 
related to change in symptoms during treatment.  
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Methods 
Participants 
From May 2008 to June 2010, 150 patients consecutively admitted to a specialized 
treatment program for PDs participated in this naturalistic, prospective study. Inclusion criteria 
were: (a) primary diagnosis of a PD according to the Structural Clinical Interview for DSM-IV 
Axis II Disorders (SCID-II; First, Spitzer, Gibbon, Williams, & Benjamin, 1997), (b) age 
between 18 and 60 years, and (c) Dutch literacy. Seventy-four percent (n = 111) of the patients 
were female, and their mean age was 28.6 years (SD = 9.3, range 18–59). Most patients (74%) 
had a cluster B PD (61% borderline PD, 11% narcissistic PD, and 2% theatrical PD). The mean 
duration of treatment was 38 weeks (SD = 12.9, range 24–65). 
 
Treatment 
Patients enrolled in a combined residential and day-hospital treatment for PD patients 
(see Vermote, Lowyck, Vandeneede, Bateman, and Luyten, 2012, for a detailed description), 
consisting of the following components: (a) group psychodynamic psychotherapy (three times a 
week for 1.5 hours); (b) nonverbal therapies (music therapy, psychomotor therapy, and creativity 
therapy; each twice a week for 1.5 hours), (c) family therapy, (d) psychiatric consultation, (e) 
weekly individual sessions with a nurse, (f) group sessions with nurses (twice a week for 45 
minutes), (g) social work, and (h) a weekly patient–staff meeting. All therapies were provided by 
professionals with an advanced degree in their discipline (MSW, MA, MD, or PhD). Patient 
progress and adherence to the treatment model were discussed at weekly staff meetings. 
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Procedure 
Patients were contacted by a research assistant during the first week of treatment. After 
obtaining informed consent and demographic information, two appointments were scheduled 
within the next week; one for the SCID-I and SCID-II clinical interviews, and the other to 
complete computerized self-report questionnaires to provide a baseline assessment (see below). 
Symptomatic distress, SCP, and dependency were also assessed after 12 and 24 weeks, and at 
discharge.  
Measures 
The SCID-I (First, Spitzer, Gibbon, & Williams, 2002) and SCID-II (First, Spitzer, 
Gibbon, Williams, & Benjamin, 1997) were used to assess symptom disorders and PDs, 
respectively. Both interviews were conducted by two experienced clinicians who were certified 
in administering and scoring the Dutch versions of the SCID-I and SCID-II (Weertman, Arntz, & 
Kerkhofs, 1996).   
Depressive Experiences Questionnaire (DEQ; Blatt, D’Afflitti, & Quinlan, 1979). The 
DEQ consists of 66 items, scored on a 7-point Likert-type scale, ranging from 1 (“I don’t 
agree”) to 7 (“I totally agree”), assessing SCP and dependency. In this study, the third factor 
(i.e., Efficacy) was not used. The DEQ factors were scored using the original factor scores of 
Blatt, D’Afflitti, and Quinlan (1976). The Dutch version of the DEQ has good internal 
consistency and validity, similar to those of the original DEQ (Luyten et al., 2007). Reliability of 
the DEQ as measured with the Cronbach alpha coefficient was 0.75.  
Brief Symptom Inventory (BSI). The BSI is a self-report questionnaire measuring 
symptomatic distress expressed in the following domains: anxiety, memory difficulties, 
depressive feelings, somatic complaints, irritability, suicidal thoughts, problems in relational 
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functioning, eating disorders, self-harm, sexual problems, sleeping problems, and substance 
abuse. In this study, a Dutch version of the inventory (Korte Klachten Lijst; Lange & Appelo, 
2007) was used. The inventory consists of 13 questions, scored on a 5-point Likert scale, ranging 
from 0 (no complaints) to 4 (many complaints). The total score (ranging from 0–52) was 
calculated by summing the scores for individual questions. The validity and reliability of the 
inventory have proven to be satisfactory (Lange & Appelo, 2007).   
Data Analysis 
A multivariate multilevel parallel growth model for change using SAS 9.2. software was 
applied (MacCallum, Kim, Malarkey, and Kiecolt-Glazer, 1997; Singer & Willett, 2003) to 
investigate (a) changes in SCP, dependency, and symptoms over the course of treatment (b) 
whether pretreatment SCP, dependency, and symptomatic distress were predictive of the changes 
in symptomatic distress over the course of treatment, and (c) whether the process of change in 
SCP, dependency, and symptomatic distress were related to one another. In this analysis, time 
was expressed in weeks since admission (with time being zero at baseline). The first three 
assessments were fixed, that is, scheduled at the same times in all patients: (a) at baseline, (b) 
after 12 weeks (3 months), and (c) after 24 weeks (6 months). The last assessment was variable, 
in that patients were assessed at discharge, which differed between patients. The model described 
above allows the study of individual differences in patterns of change of SCP, dependency, and 
symptoms over the course of treatment by examining the fixed effects, and the covariance 
parameters of the random subject-specific intercept and slope parameters of the three involved 
variables. For the interested reader, a formal and more technical description of the model used is 
provided as a supplement. Finally, it should be noted that, as missing data are almost inevitable 
in longitudinal research, inference for the proposed models is valid under the assumption of 
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missingness at random (Little & Rubin, 2002). Finally, to evaluate the effect of treatment, pre–
post standardized mean gain scores were calculated as effect sizes (ESs). The interpretation of 
these scores is the same as that for Cohen’s d (Cohen, 1988), that is, d ≤ 0.20 is considered a small 
ES, d ≈ 0.50 a medium ES, and d ≥ 0.80 a large ES.  
 
Results 
Relations between Dependency, SCP, and Symptomatic Distress at Baseline 
Dependency and SCP were not correlated at baseline (see Table 1). Pretreatment levels of 
both dependency and SCP were positively correlated with symptomatic distress at intake (see 
Table 2). 
Changes in Dependency, SCP, and Symptomatic Distress during Treatment 
Levels of dependency decreased linearly during treatment (regression coefficient for past 
weeks = -0.008 (SE = 0.002), F(1,548) = 29.81, p < .0001; ES = 0.32), representing a small ES. 
There were substantive individual differences in dependency at baseline but all patients showed a 
uniform decrease in dependency over time. For SCP, a quadratic effect of time was observed, 
which indicates that the decrease of SCP accelerated over the course of treatment (regression 
coefficient for time = -0.003 (SE = 0.005), F(1,97) = 0.34, p = .56, and for time
2 
= -0.0003 (SE = 
0.00009), F(1,548) = 8.74, p = .0032; see thick average line in Figure 1). From intake to 
treatment termination, patients showed, an average decrease of 0.70 (SE = 0.10) in levels of SCP, 
(t(72) = 6.85; p < .0001; ES = 0.82), representing a large ES. As illustrated in Figure 1, there 
were substantive individual differences in SCP at intake (i.e., the intercept) and in terms of the 
decrease of SCP during treatment (i.e., the slope). Symptomatic distress decreased linearly 
during treatment (regression coefficient = -0.19 (SE = 0.02), F(1,97) = 72.87, p < .0001), and 
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here there were also substantive individual differences in symptoms at intake and in the linear 
decrease of symptoms during treatment. On average, patients showed a decrease in symptoms of 
8.98 (SE = 1.10) between admission and discharge (t(73) = 8.19, p < .0001; ES = 1.06), 
representing a large ES.  
Role of Pretreatment Levels on Rate of Change during Treatment  
Results showed no significant associations between patients’ pretreatment levels (i.e., 
patient-specific intercepts) of SCP and changes in SCP (i.e., patient-specific slopes) and changes 
in symptoms during treatment (Table 1). Similarly, there was no significant association between 
pretreatment symptom levels (i.e., patient-specific intercepts) and changes in symptoms during 
treatment.   In general, there were no significant associations between the levels of dependency, 
SCP, and symptom distress at baseline, and the changes in these variables over the course of 
treatment. 
Dependency, SCP and Symptomatic Distress over the Course of Treatment 
Given the uniform decrease in dependency, the linear decrease of dependency is not 
associated with the decrease in SCP and symptomatic distress over time. By contrast, a linear 
decrease in SCP was associated with a decrease in symptomatic distress during treatment, as 
shown by a strong and highly significant positive correlation between subject-specific slopes for 
SCP and symptomatic distress, r = .81, Z = 2.89, p = .0038 (see Table 2).  As a result, patients 
who show a stronger (weaker) decrease in SCP are also characterized by as stronger (weaker) 
decrease in symptomatic distress over the course of treatment.  To illustrate these findings, the 
parallel process between SCP, dependency, and symptomatic distress is depicted for six patients 
in Figure 2. Patients who show a strong decrease in SCP (Figure 2b) also show strong symptom 
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reduction (Figure 2c), whereas patients who showed less change in SCP also showed a smaller 
rate of reduction in symptomatic distress.   
 
Discussion 
One of the most vexing questions in psychotherapy research concerns the challenge of 
understanding the factors that underlie therapeutic change (Kazdin, 2007). Results of this study 
further contribute to growing insights into these factors. First, in line with two-polarities models 
(e.g., Blatt, 2008), long-term, hospitalization-based psychodynamic treatment was associated not 
only with decreases in symptomatic distress, with a large effect size, but also with changes in 
maladaptive expressions of self-definition and relatedness, that is, SCP and dependency, 
respectively. For dependency, results showed a linear decrease over time, representing a small 
effect size. Further, there were no substantial differences among the patients in the rate of 
change. In other words, patients showed similar, uniform changes in levels of dependency 
throughout the treatment. SCP also decreased significantly during treatment, representing a large 
effect size. In contrast to dependency, the rate of change in SCP appeared to accelerate over the 
course of treatment, with patients reporting progressively fewer problems regarding self-
definition (e.g., by reporting being less concerned with issues related to identity, achievement, 
and failure) as their treatment progressed. Hence, although changes in issues related to self-
definition may take some time, they may be considerable and may actually accelerate as 
treatment progresses (Blatt & Shahar, 2004). This is in line with studies suggesting that SCP is 
negatively associated with treatment outcome in brief treatment, because patients with these 
features may need more time to develop a positive therapeutic alliance (Blatt, Zuroff, Hawley, & 
Auerbach, 2010).  
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Second, against expectations, pretreatment levels of SCP, dependency, and symptomatic 
distress did not predict symptom change during treatment.  Although there are substantive 
differences among patients in the decrease of SCP and symptomatic distress over the course of 
treatment, these differences cannot be predicted using patients’ baseline information on these 
variables.  For example, being extremely high or rather low on SCP at baseline does not yield 
any predictive information on change in dependency, SCP or symptomatic distress during 
treatment. Again, differences in pretreatment levels of SCP and dependency might be more 
important in brief treatments than in longer term treatment, but further research is definitely 
required in this context. 
Finally, results showed that changes in SCP, but not dependency, occurred in concert 
with symptomatic improvement during treatment. These results are in line with findings of 
earlier studies in symptom disorders such as social phobia and depression (Cox et al., 2002; 
Hawley et al., 2006) and extend these findings to the domain of PD pathology.  
Despite its strengths, this study had several limitations. First, the focus on changes in 
general symptomatic distress, as measured with a self-report measure, is an important limitation. 
Although this measure includes items assessing self-harm and suicidality as well as problems in 
interpersonal functioning, which are characteristic for personality pathology, future studies 
should include a more direct focus on personality pathology as conceptualized in Section II or 
Section III of DSM-5, and this should be assessed at different points in time throughout the 
treatment. Despite this limitation, the findings are nevertheless informative for both research and 
clinical practice. Indeed, a growing number of studies suggest that general symptomatic distress 
may be a good proxy of the general severity of PD pathology (Caspi et al., 2014; Patalay et al., 
2015) and may actually overlap with a general psychopathology factor (Caspi et al., 2014). In 
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addition, many outcome studies in the field primarily focus on changes in general symptomatic 
distress as the primary outcome measure (e.g., Clarkin et al., 2007; Leichsenring & Leibing, 
2003). Finally, only a brief symptom measure lends itself more easily to multiple assessments 
across treatment and is more sensitive to modeling change than other features of PD pathology.  
Two other limitations of the study are (a) that the study did not include a control group, it 
is impossible to rule out the possibility that these effects are indeed due only to the treatment 
process, and (b) that all variables are derived from self-report questionnaires, with exception of 
the SCID-II semi-structured interview, which was used for diagnostic purposes. However, an 
important limitation is that we did not have exact inter-rater reliability data for the raters, despite 
the fact that both raters received extensive training in the SCID-II.   
In conclusion, this study suggests that psychodynamic hospitalization-based treatment for 
patients with PDs is associated with reactivation of the normal synergistic interaction between 
the capacity for autonomy and for relatedness, resulting in lower levels of SCP,  dependency, and 
symptomatic distress.  In addition, patients show a parallel process in SCP and symptomatic 
distress over the course of treatment with patients showing a strong (weak) decrease in SCP also 
showing a strong (weak) decrease in symptomatic distress. Future studies are needed to 
investigate to what extent these findings may generalize to other treatments and other patient 
populations. 
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Table 1. Correlation matrix for random effects in multivariate multilevel model for change: 
Dependency, Self-Critical Perfectionism, and Symptomatic Distress. 
 
 Dependency Self-Critical Perfectionism Symptomatic Distress 
 
 PS-intercepts PS-intercepts PS-slopes PS-intercepts PS-slopes 
Dependency PS-intercepts 1 0.004 0.30 0.52*** -0.15 
Self-Critical 
Perfectionism 
PS- intercepts  1 -0.03 0.36** 0.03 
PS-slopes   1 0.07 0.81*** 
Symptomatic 
Distress  
PS-intercepts   
 
1 -0.16 
PS-slopes   
 
 1 
Note: PS = patient-specific, ** p < .01;*** p < .001 
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Table 2. Multivariate multilevel model for change: Fixed effects for Dependency, Self-Critical 
Perfectionism, and Symptomatic Distress. 
Note: *** p < .001; NA = Not applicable. 
 
 
 
Figure 1. Average (thick black line) and patient-specific (thin black lines) evolution of 50 
randomly selected patients for  self-critical perfectionism during treatment. 
  
Fixed Effects Regression Coefficients (SE) 
 
Dependency 
Self-Critical 
Perfectionism 
Symptomatic 
Distress 
Overall intercept 0.15 (0.09) 0.90 (0.07)*** 25.81 (0.72)*** 
Past months (linear) -0.008 (0.002)*** -0.003 (0.005) -0.19 (0.02)*** 
(Past months)
2
 (quadratic) NA -0.0003 (0.00009)*** NA 
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Figure 2. Evolution of (a) dependency, (b) SCP, and (c) symptomatic distress during treatment 
for six individual patients. 
(a) 
(b) 
(c) 
